|

Ruxolitinib Phosphate Clinical Trials

1 actively recruiting trial across 1 location

Also known as: INCB-18424 Phosphate, Jakafi, Jakavi

Pipeline

Phase 2: 1

Top Sponsors

  • City of Hope Medical Center1

Indications

  • Myelodysplastic Syndrome1
  • Acute Myeloid Leukemia1
  • Acute Lymphoblastic Leukemia1
  • Cancer1

Duarte, California1 trial

Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

City of Hope Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.